Open AccessAsparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age
Author(s) -
Cecilie Utke Rank,
Benjamin Ole Wolthers,
Kathrine Grell,
Birgitte Klug Albertsen,
Thomas Leth Frandsen,
Ulrik Malthe Overgaard,
Nina Toft,
Ove Juul Nielsen,
Peder Skov Wehner,
Arja HarilaSaari,
Mats Heyman,
Johan Malmros,
Jonas Abrahamsson,
Ulrika NorénNyström,
Beata TomaszewskaToporska,
Bendik Lund,
Kirsten Brunsvig Jarvis,
Petter QuistPaulsen,
Goda Vaitkevičienė,
Laimonas Griškevičius,
Mervi Taskinen,
Ulla WartiovaaraKautto,
Kristi Lepik,
Mari Punab,
Ólafur G. Jónsson,
Kjeld Schmiegelow
Publication year - 2020
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.19.02208
Subject(s) - medicine , odds ratio , asparaginase , hazard ratio , lymphoblastic leukemia , acute pancreatitis , pancreatitis , pediatrics , hematology , acute lymphocytic leukemia , gastroenterology , leukemia , confidence interval
Asparaginase-associated pancreatitis (AAP) is common in patients with acute lymphoblastic leukemia (ALL), but risk differences across age groups both in relation to first-time AAP and after asparaginase re-exposure have not been explored.